So Scott, our gross margins have remained stable for almost like eight quarters now, right. We've remained between that 26% to 28% range. Although, the 28% was only achieved with the Manitoba SRF. Generally, it's been around 27% so we're not too far off it at all. I said this last quarter, in my call last quarter that we have this dominating position in Canada. We're absolutely crushing it in terms of our bricks and mortar business. And we don't want to let loose on that. When you're generating $4 million a quarter prior and $5.7 million of free cash this quarter, I am not on a horse or in a hurry to raise our margins, which we clearly have an opportunity to do so. We want to really tighten up the margin, margin profile, keep it tight. So we can basically get rid of some of the noise, some of the marginal players in the country that are just there, but they really shouldn't be there, right? So that is our strategy. This is why we are holding on to the line on gross margins. We have also been pressured, to be honest, we've also been feeling the pressures from gross margin declines and sales declines in our e-commerce business, although they are all. We are still EBITDA positive in our e-commerce portfolio. There's a good strategic reasoning why we bought these assets and there's a good strategic reasoning why we are holding on to them. They're not bugging us. They're still EBITDA positive, right? A lot of our CBD competitors are no longer in business, a lot of the accessory players are no longer relevant. So we are holding the line in this tight inflationary environment, in this high inflationary environment. And we will have a chance to up the gross margin profile, not only in our brick and mortar business, basically at will when we want to do so, because we are the dominant chain in the country, but we want to get rid of a little bit of this noise in terms of marginal players that are still in the country in Canada, in the bricks and mortar business. And also be alive in our e-commerce business to play when the real inning start globally in terms of CBD and consumption accessories, and seeds, and cannabis dispensaries opening up in other countries, we will have additional gross margin opportunity. We're just being very careful on how we manage the strategy, although, it's not hurting us. We just produced $5.7 million in free cash flow.